Cargando…

Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications

The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciężki, Sebastian, Kurpiewska, Emilia, Bossowski, Artur, Głowińska-Olszewska, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243381/
https://www.ncbi.nlm.nih.gov/pubmed/35784568
http://dx.doi.org/10.3389/fendo.2022.890833
_version_ 1784738296262295552
author Ciężki, Sebastian
Kurpiewska, Emilia
Bossowski, Artur
Głowińska-Olszewska, Barbara
author_facet Ciężki, Sebastian
Kurpiewska, Emilia
Bossowski, Artur
Głowińska-Olszewska, Barbara
author_sort Ciężki, Sebastian
collection PubMed
description The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in children’s population complicates differential diagnosis of the type of diabetes in youths. Coexistence of obesity has clinical implications for all stages of diabetes course. It is confirmed that obesity is the risk factor for autoimmune diabetes, and is connected with the earlier onset of diabetes in predisposed patients. Many diabetic patients with obesity present additional risk factors for macroangiopathy, and are recognised to present metabolic syndrome, insulin resistance, and typical for diabetes type 2 - polycystic ovary syndrome, or non-alcoholic fatty liver disease. The prevalence of obesity rises dramatically in adolescence of diabetic child, more often in girls. It has negative impact on metabolic control, glycaemic variability and insulin demand. The risk for microangiopathic complications increases as well. The treatment is difficult and includes not only insulinotherapy and non-pharmacological trials. Recently treatment of insulin resistance with biguanids, and treatment with typical for type 2 new diabetes drugs like GLP-1 analogues, SGLT-2 receptor inhibitors, or even cases of bariatric surgery also has been reported.
format Online
Article
Text
id pubmed-9243381
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92433812022-07-01 Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications Ciężki, Sebastian Kurpiewska, Emilia Bossowski, Artur Głowińska-Olszewska, Barbara Front Endocrinol (Lausanne) Endocrinology The prevalence of overweight and obesity among youth patients with diabetes type 1 is increasing. It is estimated, that even up to 35% of young patients with this type of diabetes, considered so far to be characteristic for slim figure, are overweight or even obese. General increase of obesity in children’s population complicates differential diagnosis of the type of diabetes in youths. Coexistence of obesity has clinical implications for all stages of diabetes course. It is confirmed that obesity is the risk factor for autoimmune diabetes, and is connected with the earlier onset of diabetes in predisposed patients. Many diabetic patients with obesity present additional risk factors for macroangiopathy, and are recognised to present metabolic syndrome, insulin resistance, and typical for diabetes type 2 - polycystic ovary syndrome, or non-alcoholic fatty liver disease. The prevalence of obesity rises dramatically in adolescence of diabetic child, more often in girls. It has negative impact on metabolic control, glycaemic variability and insulin demand. The risk for microangiopathic complications increases as well. The treatment is difficult and includes not only insulinotherapy and non-pharmacological trials. Recently treatment of insulin resistance with biguanids, and treatment with typical for type 2 new diabetes drugs like GLP-1 analogues, SGLT-2 receptor inhibitors, or even cases of bariatric surgery also has been reported. Frontiers Media S.A. 2022-06-16 /pmc/articles/PMC9243381/ /pubmed/35784568 http://dx.doi.org/10.3389/fendo.2022.890833 Text en Copyright © 2022 Ciężki, Kurpiewska, Bossowski and Głowińska-Olszewska https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Ciężki, Sebastian
Kurpiewska, Emilia
Bossowski, Artur
Głowińska-Olszewska, Barbara
Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
title Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
title_full Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
title_fullStr Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
title_full_unstemmed Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
title_short Multi-Faceted Influence of Obesity on Type 1 Diabetes in Children – From Disease Pathogenesis to Complications
title_sort multi-faceted influence of obesity on type 1 diabetes in children – from disease pathogenesis to complications
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243381/
https://www.ncbi.nlm.nih.gov/pubmed/35784568
http://dx.doi.org/10.3389/fendo.2022.890833
work_keys_str_mv AT ciezkisebastian multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications
AT kurpiewskaemilia multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications
AT bossowskiartur multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications
AT głowinskaolszewskabarbara multifacetedinfluenceofobesityontype1diabetesinchildrenfromdiseasepathogenesistocomplications